Pfizer, Takeda and Alphabet-backed degenerative disease drug developer Cortexyme priced its initial public offering in the middle of its range to raise $75m.

Corporate joint venture Echo Health Ventures led a $33m funding round that will help fund the home care access platform's expansion in the US.

GV led a $58.5m round for the heart disease drug developer, which is advancing research conducted at Harvard University and Broad Institute and has a partnership in place with Harvard spinout Beam Therapeutics.

TigerMed-backed brain monitor developer Neural Analytics boosted its total funding to $66m in a series C round led by existing investor Alpha Edison.

Osage University Partners has invested in LunaPBC, the public benefit corporation responsible for operating the community-owned LunaDNA genetic and health data collection platform.

Bill Brizzard will end his tenure as executive director of Indiana University’s Innovation and Commercialization Office to be replaced by Karen White on a temporary basis.

UCLA spinout Neural Analytics increased its total funding to $66m as it prepares for further testing of its robotically-assisted brain health monitoring platform.

MIT-run social enterprise incubator MIT Solve is to gain an impact investment fund with a $30m target size to back participants in its annual Global Challenges innovation contest.

Intel Capital vice-president and managing director Keith Larson has announced his retirement, ending a career at the unit that spanned more than 22 years.

Brookfield Ventures led the leasing and asset management platform's series D round, investing alongside Tishman Speyer and GLP.